Okazaki, Japan

Motohiro Nishida

This inventor holds 1 USPTO granted patent. Top assignees: Inter-University Research Institute Corporation National Institutes of Natural Sciences, Kyoto University, Osaka University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Motohiro Nishida. Retrieved from https://idiyas.com/inventor/motohiro-nishida

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Motohiro Nishida: Innovator in Benzisoxazole Compounds

Introduction

Motohiro Nishida is a notable inventor based in Okazaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic potential.

Latest Patents

Nishida holds a patent for a benzisoxazole compound, which is effective for preventing and/or treating fibrosis. The compound is represented by a specific formula that includes various chemical components, such as an optionally substituted benzene ring and other functional groups. This innovation highlights his expertise in creating compounds that can address serious health conditions.

Career Highlights

Throughout his career, Motohiro Nishida has worked with prestigious institutions, including Osaka University and Kyoto University. His work in these academic environments has allowed him to advance his research and contribute to the scientific community.

Collaborations

Nishida has collaborated with esteemed colleagues, including Ryu Nagata and Yasuo Mori. These partnerships have likely enriched his research and led to further advancements in his field.

Conclusion

Motohiro Nishida's contributions to the development of benzisoxazole compounds demonstrate his commitment to innovation in medicinal chemistry. His work continues to have a positive impact on the treatment of fibrosis and related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…